Tetra Bio-Pharma Signs Co-development and Distribution Partnership

Tetra Bio-Pharma (TSXV:TBP; OTCQB:TBPMF) announced it signed a co-development and distribution agreement with an undisclosed specialty healthcare distributor.

As quoted in the press release:

The finalization of the term sheet follows Tetra’s September 20, 2017 Letter of Intent for a co-development and distribution partnership with the same privately held company in the specialty healthcare market. The company has a pan-Canadian distribution network that reaches up to 7000 specialized healthcare professionals. Through their distribution channel, they have access to more than 3000 specialized healthcare businesses in Canada and already work with a worldwide network of partners.

Management Statement

“We are very pleased to sign this term sheet as it solidifies the elements of the LOI outlined in September. We are continually striving and working hard every day to both solidify and grow Tetra as a major player in cannabinoid pharma and this is yet again a step in that direction. I am excited to continue to build on the momentum that we have going for us now and throughout 2018,” says Bernard Fortier, CEO of Tetra.

Click here to read the full press release.